Johnston G A
Adrien Albert Laboratory of Medicinal Chemistry, Department of Pharmacology, University of Sydney, NSW, Australia.
Trends Pharmacol Sci. 1996 Sep;17(9):319-23.
The inhibitory neurotransmitter, GABA, activates a variety of receptors in all areas of the CNS. Two major subtypes of GABA receptors are well known: (1) GABAA receptors are ligand-gated Cl- channels that consist of a heteromeric mixture of protein subunits forming a pentameric structure, and (2) GABAB receptors couple to Ca2+ and K+ channels via G proteins and second messengers. Here, Graham Johnston discusses evidence for a third major subclass of GABA receptors. GABAC receptors appear to be relatively simple ligand-gated Cl- channels with a distinctive pharmacology, in that they are not blocked by bicuculline and not modulated by barbiturates, benzodiazepines or neuroactive steroids. Compared with GABAA receptors, GABAC receptors are activated at lower concentrations of GABA and are less liable to desensitization. In addition, their channels open for a longer time. The pharmacology of these novel subtypes of GABA receptors may yield important therapeutic agents.
抑制性神经递质γ-氨基丁酸(GABA)可激活中枢神经系统所有区域的多种受体。GABA受体有两种主要的亚型,广为人知:(1)GABAA受体是配体门控氯离子通道,由形成五聚体结构的蛋白质亚基异源混合物组成;(2)GABAB受体通过G蛋白和第二信使与钙离子和钾离子通道偶联。在此,格雷厄姆·约翰斯顿讨论了GABA受体第三种主要亚类的证据。GABAC受体似乎是相对简单的配体门控氯离子通道,具有独特的药理学特性,即它们不受荷包牡丹碱阻断,也不受巴比妥类药物、苯二氮䓬类药物或神经活性甾体的调节。与GABAA受体相比,GABAC受体在较低浓度的GABA作用下被激活,且不易脱敏。此外,它们的通道开放时间更长。这些新型GABA受体亚型的药理学特性可能会产生重要的治疗药物。